<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Orbital</provider_name><provider_url>https://www.orbital-itn.eu</provider_url><author_name>hammad</author_name><author_url>https://www.orbital-itn.eu/author/hammad/</author_url><title>Project 2: Intrascleral Delivery of anti-VEGF to the Posterior of the Eye using Microneedle devices - Orbital</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content"&gt;&lt;a href="https://www.orbital-itn.eu/projects/project-2-intrascleral-delivery-of-anti-vegf-to-the-posterior-of-the-eye-using-microneedle-devices/"&gt;Project 2: Intrascleral Delivery of anti-VEGF to the Posterior of the Eye using Microneedle devices&lt;/a&gt;&lt;/blockquote&gt;
&lt;script type='text/javascript'&gt;
&lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
		/*! This file is auto-generated */
		!function(d,l){"use strict";var e=!1,o=!1;if(l.querySelector)if(d.addEventListener)e=!0;if(d.wp=d.wp||{},!d.wp.receiveEmbedMessage)if(d.wp.receiveEmbedMessage=function(e){var t=e.data;if(t)if(t.secret||t.message||t.value)if(!/[^a-zA-Z0-9]/.test(t.secret)){var r,a,i,s,n,o=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),c=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]');for(r=0;r&lt;c.length;r++)c[r].style.display="none";for(r=0;r&lt;o.length;r++)if(a=o[r],e.source===a.contentWindow){if(a.removeAttribute("style"),"height"===t.message){if(1e3&lt;(i=parseInt(t.value,10)))i=1e3;else if(~~i&lt;200)i=200;a.height=i}if("link"===t.message)if(s=l.createElement("a"),n=l.createElement("a"),s.href=a.getAttribute("src"),n.href=t.value,n.host===s.host)if(l.activeElement===a)d.top.location.href=t.value}}},e)d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",t,!1),d.addEventListener("load",t,!1);function t(){if(!o){o=!0;var e,t,r,a,i=-1!==navigator.appVersion.indexOf("MSIE 10"),s=!!navigator.userAgent.match(/Trident.*rv:11\./),n=l.querySelectorAll("iframe.wp-embedded-content");for(t=0;t&lt;n.length;t++){if(!(r=n[t]).getAttribute("data-secret"))a=Math.random().toString(36).substr(2,10),r.src+="#?secret="+a,r.setAttribute("data-secret",a);if(i||s)(e=r.cloneNode(!0)).removeAttribute("security"),r.parentNode.replaceChild(e,r)}}}}(window,document);
//--&gt;&lt;!]]&gt;
&lt;/script&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.orbital-itn.eu/projects/project-2-intrascleral-delivery-of-anti-vegf-to-the-posterior-of-the-eye-using-microneedle-devices/embed/" width="600" height="338" title="&#x201C;Project 2: Intrascleral Delivery of anti-VEGF to the Posterior of the Eye using Microneedle devices&#x201D; &#x2014; Orbital" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;</html><thumbnail_url>https://www.orbital-itn.eu/app/uploads/2020/03/orbital-partner-icon-2@2x.png</thumbnail_url><thumbnail_width>530</thumbnail_width><thumbnail_height>226</thumbnail_height><description>Chronic retinal diseases are the leading contributor to visual impairment and blindness that are potentially the most devastating health problem worldwide. The World Health Organization estimates that globally about 285M people are visually impaired, of which 39M are blind and 246M have low vision. Diseases that originate in the posterior segment (PS) or back of &hellip; Read More</description></oembed>
